IDT Biologika Overview

  • Year Founded
  • 1921

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,800

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 4

IDT Biologika General Information

Description

Manufacturer of biotechnology-based vaccines and pharmaceuticals designed to improve the health of humans and animals. The company's vaccines and pharmaceuticals are sterile, injectable and bioengineered and are made out of prophylactic and therapeutic biologics making them capable of fighting against infectious diseases enabling international biopharmaceutical companies to combat diseases and epidemics worldwide.

Contact Information

Formerly Known As
Bakteriologisches Institut der Anhaltischen Kreise
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Am Pharmapark
  • 06861 Dessau-Rosslau
  • Germany
+49 034901
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Corporate Office
  • Am Pharmapark
  • 06861 Dessau-Rosslau
  • Germany
+49 034901

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IDT Biologika Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IDT Biologika‘s full profile, request access.

Request a free trial

IDT Biologika Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of biotechnology-based vaccines and pharmaceuticals designed to improve the health of humans and animals. T
Other Pharmaceuticals and Biotechnology
Dessau-Rosslau, Germany
1,800 As of 2024

Kolkata, India
 

PA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IDT Biologika Competitors (29)

One of IDT Biologika’s 29 competitors is TCG Lifesciences, a Corporation company based in Kolkata, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TCG Lifesciences Corporation Kolkata, India
Vector Biolabs Corporation PA
CordenPharma Private Equity-Backed Basel, Switzerland
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
OncoResponse Venture Capital-Backed Houston, TX
You’re viewing 5 of 29 competitors. Get the full list »

IDT Biologika Patents

IDT Biologika Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020115329-A1 A recombinant koi herpesvirus (khv) and a diva vaccine for preventing and/or treating a disease caused by khv Inactive 07-Dec-2018
EP-2949340-A1 Vaccine composition against streptococcus suis infection Inactive 30-May-2014
US-20170209561-A1 Vaccine composition against streptococcus suis infection Inactive 30-May-2014
WO-2015181356-A1 Vaccine composition against streptococcus suis infection Inactive 30-May-2014
WO-2015181356-A8 Vaccine composition against streptococcus suis infection Inactive 30-May-2014 A61K39/092
To view IDT Biologika’s complete patent history, request access »

IDT Biologika Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IDT Biologika Acquisitions (4)

IDT Biologika’s most recent deal was a Merger/Acquisition with Ridgeway Biologicals. The deal was made on 05-Jan-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ridgeway Biologicals 05-Jan-2017 Merger/Acquisition Drug Discovery
Gallant Custom Laboratories 31-Aug-2015 Merger/Acquisition Other Consumer Non-Durables
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) 23-Jun-2015 Merger/Acquisition Drug Discovery
RIEMSER Arzneimittel (Animal Health Business) 01-Aug-2013 Merger/Acquisition Drug Delivery
To view IDT Biologika’s complete acquisitions history, request access »

IDT Biologika Exits (1)

IDT Biologika’s most recent exit was on 05-Jan-2017 from Ridgeway Biologicals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Ridgeway Biologicals 05-Jan-2017 Completed
To view IDT Biologika’s complete exits history, request access »

IDT Biologika Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Gallant Custom Laboratories Cambridge, Canada 1995

IDT Biologika FAQs

  • When was IDT Biologika founded?

    IDT Biologika was founded in 1921.

  • Where is IDT Biologika headquartered?

    IDT Biologika is headquartered in Dessau-Rosslau, Germany.

  • What is the size of IDT Biologika?

    IDT Biologika has 1,800 total employees.

  • What industry is IDT Biologika in?

    IDT Biologika’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is IDT Biologika a private or public company?

    IDT Biologika is a Private company.

  • What is the current valuation of IDT Biologika?

    The current valuation of IDT Biologika is .

  • What is IDT Biologika’s current revenue?

    The current revenue for IDT Biologika is .

  • How much funding has IDT Biologika raised over time?

    IDT Biologika has raised $324M.

  • Who are IDT Biologika’s competitors?

    TCG Lifesciences, Vector Biolabs, CordenPharma, Charles River Laboratories International, and OncoResponse are some of the 29 competitors of IDT Biologika.

  • When was IDT Biologika acquired?

    IDT Biologika was acquired on 01-Oct-2024.

  • Who acquired IDT Biologika?

    IDT Biologika was acquired by SK Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process